Literature DB >> 19908171

Gastroenteropancreatic neuroendocrine tumors: 10-year experience in a single center.

Ozcan Yildiz1, Mustafa Ozguroglu, Teoman Yanmaz, Hande Turna, Suheyla Serdengecti, Gulen Dogusoy.   

Abstract

Neuroendocrine tumors originate from neuroendocrine cells and occur in a wide spectrum from carcinoid tumors to small cell carcinomas. Although the World Health Organization determined clinical and histological features to predict prognosis for such tumors, they may not be valid on an individual basis. This study investigates the clinical, pathologic and prognostic characteristics of gastroenteropancreatic neuroendocrine tumors that presented to the Medical Oncology Outpatient Clinic, İstanbul University, Cerrahpaşa School of Medicine from 1995 to 2006 (n=86). The mean age of the patients was 52±14 and the male-to-female ratio was 0.87. The most common site of involvement was the stomach. Midgut intestinal tumors seemed to have significant female predominance compared to hindgut intestinal tumors (P=0.016). Most of the patients had metastatic disease with a prevalence of 34.9%. Poorly differentiated tumors and mixed neuroendocrine carcinomas were significantly larger than 2 cm (P=0.0001). The median survival was 139 months and the highest mortality was for colorectal tumors (36%). While univariate analysis revealed that the number of lymph nodes (P=0.008), multiple foci (P=0.034), metastases (P=0.022) and stage (P=0.034) correlated significantly with survival, there was no independent variable in the multivariate analysis. Hindgut tumors had significantly more Ki-67, mitosis and necrosis compared to others (P≤0.05). In this retrospective study, the clinical, pathologic and prognostic characteristics of gastroenteropancreatic tumors from a single center from Turkey were analyzed and compared with the current medical literature.

Entities:  

Mesh:

Year:  2009        PMID: 19908171     DOI: 10.1007/s12032-009-9332-7

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  13 in total

1.  The classification of carcinoid tum ours.

Authors:  E D WILLIAMS; M SANDLER
Journal:  Lancet       Date:  1963-02-02       Impact factor: 79.321

2.  Epidemiology and survival in patients with carcinoid disease in The Netherlands. An epidemiological study with 2391 patients.

Authors:  P F Quaedvlieg; O Visser; C B Lamers; M L Janssen-Heijen; B G Taal
Journal:  Ann Oncol       Date:  2001-09       Impact factor: 32.976

Review 3.  Gastrointestinal carcinoid tumors and second primary malignancies.

Authors:  N Habal; C Sims; A J Bilchik
Journal:  J Surg Oncol       Date:  2000-12       Impact factor: 3.454

4.  Bronchial carcinoid tumors: a retrospective analysis of 126 patients.

Authors:  D H Harpole; J M Feldman; S Buchanan; W G Young; W G Wolfe
Journal:  Ann Thorac Surg       Date:  1992-07       Impact factor: 4.330

5.  Carcinoid tumors. An analysis of 2,837 cases.

Authors:  J D Godwin
Journal:  Cancer       Date:  1975-08       Impact factor: 6.860

6.  ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis.

Authors:  G Rindi; C Azzoni; S La Rosa; C Klersy; D Paolotti; S Rappel; M Stolte; C Capella; C Bordi; E Solcia
Journal:  Gastroenterology       Date:  1999-03       Impact factor: 22.682

7.  Carcinoid tumours. Frequency in a defined population during a 12-year period.

Authors:  T Berge; F Linell
Journal:  Acta Pathol Microbiol Scand A       Date:  1976-07

8.  Gastrointestinal carcinoid tumors: factors that predict outcome.

Authors:  Jamie J Van Gompel; Rebecca S Sippel; Tom F Warner; Herbert Chen
Journal:  World J Surg       Date:  2004-03-04       Impact factor: 3.352

9.  A 5-decade analysis of 13,715 carcinoid tumors.

Authors:  Irvin M Modlin; Kevin D Lye; Mark Kidd
Journal:  Cancer       Date:  2003-02-15       Impact factor: 6.860

10.  Neuroendocrine differentiation in colorectal carcinomas: assessing its prognostic significance.

Authors:  Pinar Atasoy; Arzu Ensari; Salim Demirci; Nazmiye Kurşun
Journal:  Tumori       Date:  2003 Jan-Feb
View more
  6 in total

1.  Neuroendocrine carcinoma of the stomach: clinicopathological and immunohistochemical evaluation.

Authors:  Tsutomu Namikawa; Toyokazu Oki; Hiroyuki Kitagawa; Takehiro Okabayashi; Michiya Kobayashi; Kazuhiro Hanazaki
Journal:  Med Mol Morphol       Date:  2013-01-10       Impact factor: 2.309

2.  Neuroendocrine tumors involving the gastroenteropancreatic tract: a clinicopathological evaluation of 773 cases.

Authors:  Bruna Estrozi; Carlos E Bacchi
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

3.  Different somatostatin and CXCR4 chemokine receptor expression in gastroenteropancreatic neuroendocrine neoplasms depending on their origin.

Authors:  Rebekka Mai; Daniel Kaemmerer; Tina Träger; Elisa Neubauer; Jörg Sänger; Richard P Baum; Stefan Schulz; Amelie Lupp
Journal:  Sci Rep       Date:  2019-03-13       Impact factor: 4.379

4.  Clinicopathologic Features of Gastroenteropancreatic Neuroendocrine Tumors: A Single-center Experience

Authors:  Tuğba Akın Telli; Ece Esin; Şuayib Yalçın
Journal:  Balkan Med J       Date:  2020-06-23       Impact factor: 2.021

5.  Surgical treatment and prognosis of gastric neuroendocrine neoplasms: a single-center experience.

Authors:  Chaoyong Shen; Huijiao Chen; Haining Chen; Yuan Yin; Luyin Han; Jiaju Chen; Sumin Tang; Xiaonan Yin; Zongguang Zhou; Bo Zhang; Zhixin Chen
Journal:  BMC Gastroenterol       Date:  2016-09-09       Impact factor: 3.067

6.  Liver Metastasis of Gastrointestinal Neuroendocrine Tumors: A Single Center Experience.

Authors:  Bita Geramizadeh; Ali Kashkooe; Seyed Ali Malekhosseini
Journal:  Hepat Mon       Date:  2016-04-30       Impact factor: 0.660

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.